<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Visualization 3 - Choropleth Map</title>
  <link rel="stylesheet" href="style.css">
  <script src="https://d3js.org/d3.v7.min.js"></script>
  <script src="https://unpkg.com/topojson@3"></script>
  <style>
    body {
      margin: 0;
      font-family: Arial, sans-serif;
      background-color: #f0f6ff;
      color: #03396c;
    }
    header, footer {
      background-color: #005b96;
      color: white;
      padding: 1rem;
      text-align: center;
    }
    nav {
      background-color: #6497b1;
      padding: 1rem;
      text-align: center;
    }
    nav a {
      margin: 0 15px;
      color: white;
      text-decoration: none;
      font-weight: bold;
    }
    section {
      max-width: 1200px;
      margin: auto;
      padding: 2rem;
      background-color: white;
      margin-top: 1rem;
      border-radius: 8px;
      box-shadow: 0 0 10px rgba(0, 91, 150, 0.1);
      overflow-x: auto;
    }
    .viz-container {
      margin-top: 2rem;
      width: 100%;
      height: auto;
    }
    h2 {
      color: #011f4b;
    }
  </style>
</head>
<body>
  <header>
    <h1>Predicting Alzheimer’s Disease</h1>
    <p>Visualization 1: Choropleth Map of Prevalence by Country</p>
  </header>

  <nav>
    <a href="index.html">Introduction</a>
    <a href="visualization1.html">Prevalence by Country</a>
    <a href="visualization2.html">Age Distribution</a>
    <a href="visualization3.html">Alzheimer’s Factor Analysis</a>
    <a href="visualization4.html">Risk Factors Across NA</a>
    <a href="visualization5.html">Family History Risk</a>
    <a href="conclusion.html">Conclusion</a>
  </nav>

  <section>
    <h2>Global Prevalence of Alzheimer’s Diagnosis</h2>
    <p>This interactive choropleth map illustrates the percentage of individuals diagnosed with Alzheimer’s disease across countries worldwide. Darker shades indicate a higher percentage of the population diagnosed. By visualizing geographic variation in diagnosis prevalence, we can better understand disparities that may stem from healthcare access, environmental factors, or genetic predisposition.</p>

    <div id="map" class="viz-container"></div>

    <h3>Interpretation</h3>
    <p>Countries like Mexico and the United States show higher prevalence, likely due to a combination of age demographics, awareness, diagnosis rates, and underlying health and genetic risk factors. Lighter-colored countries either have lower prevalence or are not represented in the dataset.</p>
  </section>

  <footer>
    <p>DS4200 - Spring 2025</p>
  </footer>

  <script src="map.js"></script>
</body>
</html>
